NCT01898234View on ClinicalTrials.gov

Dialysis Membranes and Hemodynamic Tolerance

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Dialysis Membranes and Hemodynamic Tolerance
Interventions
DEVICE

Revaclear

Four polysulfone dialyzers of 1.8 m2, A (Revaclear, Gambro), B (Helixone high flux, Fresenius), C (Xevonta, BBraun) and D (Helixone low flux, Fresenius), were compared with each other

DEVICE

Helixone high flux

Four polysulfone dialyzers of 1.8 m2, A (Revaclear, Gambro), B (Helixone high flux, Fresenius), C (Xevonta, BBraun) and D (Helixone low flux, Fresenius), were compared with each other

DEVICE

Xevonta

Four polysulfone dialyzers of 1.8 m2, A (Revaclear, Gambro), B (Helixone high flux, Fresenius), C (Xevonta, BBraun) and D (Helixone low flux, Fresenius), were compared with each other

DEVICE

Helixone low flux

Four polysulfone dialyzers of 1.8 m2, A (Revaclear, Gambro), B (Helixone high flux, Fresenius), C (Xevonta, BBraun) and D (Helixone low flux, Fresenius), were compared with each other

Trial Locations (1)

6928

Ospedale Regionale di Locarno, Locarno

All Listed Sponsors
lead

Ospedale Regionale di Locarno

OTHER

NCT01898234 - Dialysis Membranes and Hemodynamic Tolerance | Biotech Hunter | Biotech Hunter